361 studies found for:    Williams Syndrome
Show Display Options
Rank Status Study
21 Recruiting Thalamic Deep Brain Stimulation for the Treatment of Refractory Tourette Syndrome
Condition: Tourette Syndrome
Intervention: Device: Medtronic Activa Deep Brain Stimulation System
22 Unknown  Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity
Conditions: Obesity;   Metabolic Syndrome X
Interventions: Drug: Metformin;   Drug: Orlistat;   Drug: Topiramate;   Drug: Placebo
23 Recruiting Natural History Study of Smith-Magenis Syndrome
Conditions: Chromosome Abnormalities;   Smith Magenis Syndrome
Intervention:
24 Recruiting Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
Conditions: Albinism;   Intestinal Disease;   Kidney Disease;   Myocardial Disease;   Pulmonary Fibrosis
Intervention:
25 Recruiting Treatment Strategies for Children With Smith-Magenis Syndrome
Conditions: Developmental Delay Disorders;   Chromosome Deletion;   Mental Retardation;   Sleep Disorders, Circadian Rhythm;   Self Injurious Behavior
Interventions: Drug: dTR Melatonin (NIH CC PDS);   Device: Phototherapy (Bright Light);   Drug: Melatonin CR
26 Unknown  Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells
Conditions: Acute Leukemia;   Chronic Leukemia;   Myelodysplastic Syndrome;   Lymphoma;   Myeloma
Intervention: Other: Ex vivo expanded cord blood cells
27 Not yet recruiting Efficacy of Platelet Rich Plasma vs. Corticosteroid Injections for Treating Greater Trochanteric Pain Syndrome
Condition: Greater Trochanteric Pain Syndrome
Interventions: Drug: Triamcinolone Acetonide;   Other: Platelet Rich Plasma
28 Completed Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome
Condition: Sleep Apnea, Obstructive
Intervention: Drug: Modafinil
29 Recruiting Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia;   Chronic Myelomonocytic Leukemia;   de Novo Myelodysplastic Syndromes;   Previously Treated Myelodysplastic Syndromes
Interventions: Drug: lenalidomide;   Biological: epoetin alfa;   Other: laboratory biomarker analysis
30 Terminated Phase III Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Interventions: Drug: Apixaban;   Drug: Placebo
31 Completed PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome
Conditions: Narcolepsy;   Sleep Apnea, Obstructive
Intervention: Drug: Modafinil
32 Recruiting Cardiovascular Inflammation Reduction Trial
Condition: Cardiovascular Disease
Interventions: Drug: Methotrexate;   Drug: Placebo
33 Active, not recruiting
Has Results
Oral Contraceptives in the Metabolic Syndrome
Conditions: Metabolic Syndrome X;   Insulin Resistance;   Obesity;   Cardiovascular Diseases
Intervention: Drug: Ortho Tri Cyclen
34 Unknown  Assessment of Near Infrared Spectroscopy as a Diagnostic Tool in Acute Compartment Syndrome
Condition: Compartment Syndrome
Intervention: Device: near-infrared spectroscopy
35 Completed Susceptibility to Chronic Post-Traumatic Extremity Pain
Condition: Chronic Pain
Intervention:
36 Unknown  Rituximab in Patients With Relapsed or Refractory TTP-HUS
Conditions: Thrombotic Thrombocytopenic Purpura;   Hemolytic Uremic Syndrome
Intervention: Drug: Rituximab
37 Completed Comparison of Aneuploidy Risk Evaluations
Conditions: Pregnancy;   Down Syndrome;   Edwards Syndrome;   Patau Syndrome;   Turners Syndrome
Intervention:
38 Completed A Study to Evaluate the Effect of Losmapimod on Cardiac Conduction as Compared to Placebo and Moxifloxacin
Condition: Acute Coronary Syndrome
Interventions: Drug: Losmapimod;   Drug: Moxifloxacin;   Drug: Losmapimod matched Placebo;   Drug: Moxifloxacin Placebo
39 Unknown  The Use of Near Infrared Spectroscopy in the Diagnosis of Acute Compartment Syndrome
Condition: Acute Compartment Syndrome
Intervention: Device: Near infrared spectroscopy (NIRS)
40 Recruiting Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
Conditions: Down Syndrome;   Fetal Aneuploidy
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years